Clinical Trial Update: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma [Phase 1, Phase 2]

View source ↗

Summary

This entry reports the completion and posted results of a Phase 1/2 trial evaluating erlotinib in combination with temsirolimus for recurrent malignant glioma. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Diffuse Astrocytoma
• Glioblastoma
• Gliosarcoma
• Mixed Glioma
• Pilocytic Astrocytoma
• Subependymal Giant Cell Astrocytoma

Drugs mentioned

• Tarceva (erlotinib)
• Torisel (Temsirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-06-15